Evidence map›Paper›PMID 41249894›Full record

ArticleThe Australian & New Zealand journal of obstetrics & gynaecology2026

Demographic Factors Influencing Eligibility for EMA in South Australia.

Laura Slade, Jennie Louise, Katina D'Onise, Jodie Dodd

Abstract read
In one paragraph

Article in The Australian & New Zealand journal of obstetrics & gynaecology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Demographic Factors Influencing Eligibility for EMA in South Australia.The Australian & New Zealand journal of obstetrics & gynaecology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Laura SladeWomen's and Children's Hospital, North Adelaide, South Australia, Australia.ORCID 0000-0001-8425-9359
Jennie LouiseWomen's and Children's Hospital Research Institute, Women's and Children's Hospital, North Adelaide, South Australia, Australia.
Katina D'OniseSchool of Public Health, University of Adelaide, Adelaide, South Australia, Australia.
Jodie DoddWomen's and Children's Hospital, North Adelaide, South Australia, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEarly medical abortion (EMA) can be performed by administration of mifepristone and misoprostol in an outpatient setting prior to 63 days gestation in Australia. While this is a flexible, efficacious and safe option for abortion, it requires early identification of pregnancy and efficient access to a clinical service. Outpatient EMA with mifepristone and misoprostol was introduced in Australia in 2012 for gestations < 49 days, and extended to 63 days in 2015.

methodsThe laws governing abortion in South Australia mandate routine data collection. A retrospective cohort study was conducted of all registered abortions in South Australia from 2012 to 2020. Women undergoing abortion before 7 weeks gestation between 2012 and 2014 and then from 2015 those undergoing abortion before 9 weeks gestation were considered EMA eligible. Demographic characteristics were then compared using multiple logistic regression.

resultsWomen who were eligible for EMA were significantly different from those who were ineligible based on gestational age. Women who were ineligible were more likely to be teenagers, live in rural and remote areas and live in areas of socio-economic disadvantage. In multivariable logistic regression teenagers were disproportionately less likely to be EMA eligible, with rural women and socially disadvantaged teenagers having the lowest rates of and eligibility for EMA.

conclusionEligibility for EMA was affected by age, rurality and socio-economic disadvantage. Interventions to improve access should investigate and address the specific barriers facing these groups of women.

Indexed as

Abortion, InducedEligibility DeterminationMifepristoneMisoprostolAdolescentAdultFemaleGestational AgeHumansLogistic ModelsPregnancyRetrospective StudiesRural PopulationSouth AustraliaYoung AdultMifepristoneMisoprostolabortion accesshealthcare equitytermination of pregnancy

Identifiers

PMID41249894
PMCPMC12874196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.